ECT has been shown to enhance VEGF levels in TRD patients [64]; moreover, lower VEGF concentrations have been described to predict a lack of response to ECT, indicating that this neurotrophin could represent a predictive biomarker for treatment outcome [65,66]. Here, BDNF is linked to treatment resistant depression.